CTVA
Corteva
Materials · Fertilizers & Agricultural Chemicals · US
✓ ETHICAL PASS
NARROW MOAT
HIGH
Data Confidence: 100.0%
Key Metrics
How this company measures up on the fundamentals that matter
Market Cap
$55.1B
Total market value of the company
44.55
Expensive — high growth expected
20.16
Based on estimated future earnings — lower means cheaper
Rev Growth
+11.0%
Year-over-year revenue change
Profit Margin
6.5%
How much profit the company keeps from each dollar of revenue
5.1%
Return on equity — how efficiently it uses shareholder money
Analyst Target
$89.38
+16% from current price — median analyst estimate
Recommendation
BUY
Consensus view from 21 analysts covering this stock
About Corteva
Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. The company was founded in 1802 and is headquartered in Indianapolis, Indiana.
https://www.corteva.com
Country: United States Employees: 21,500 Industry: Agricultural Inputs
Ethical Screening
Five compliance checks based on AAOIFI standards — all must pass for ethical clearance
Business Activity
PASS
Core business does not involve prohibited activities
Debt Ratio
6.0% PASS
Debt must be below 33% of total assets
Cash Ratio
0.4% PASS
Interest-bearing cash below 33% of assets
Receivables
22.3% PASS
Receivables below 49% of assets
Revenue Purity
0.8% PASS
Non-compliant revenue below 5% — any excess requires purification
Valuation
$49.05
What our model estimates this business is worth per share
-57.0%
Trading above fair value — no margin of safety
Rating
OVERVALUED
Overall assessment combining ethics, valuation, and quality
91.4th
Ranks in the top 9% of our 13,571 screened universe
Trading at $82, 68% above fair value of $49. Passes all ethical screens. Ranks better than 55% of screened stocks.
Quantitative Intelligence
Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data
DISTRIBUTION
Smart money appears to be selling into strength — caution
0.882
Good returns relative to risk taken
0.0713
Suggested allocation is meaningful — the edge justifies a position
0.997
Acceptable balance between returns and drawdown risk
Annual Return
20.6%
Historical annualised return based on price data
-20.7%
Largest peak-to-trough decline — the worst it has been
SIDEWAYS
Price consolidating — no clear directional bias
Days in State
147
How long the current regime has persisted — longer means more stable
Market Data
Trading characteristics and market positioning
0.59
Less volatile than the market — more defensive
52W High
$85.63
10% below the year high
52W Low
$60.54
27% above the year low
Avg Volume
3,967,904
Average daily shares traded — higher means easier to buy and sell
4.4
Days it would take all short sellers to cover — higher means more crowded
Short % Float
2.6%
Low short interest — limited bearish positioning
0.9%
Annual dividend as a percentage of the share price
$1.85
Earnings per share over the last 12 months
Financial Health
Balance sheet strength and cash generation — the foundation of long-term value
0.14
Conservative use of debt — low financial risk
1.47
Adequate but worth monitoring
Quick Ratio
0.90
Like current ratio but excludes inventory — stricter test
Gross Margin
48.6%
Revenue left after cost of goods — higher means pricing power
Operating Margin
23.7%
Profit from core operations before interest and tax
$2.6B
Positive — the business generates more cash than it spends
Revenue (TTM)
$17.9B
Total revenue over the last 12 months
Net Income
$1.3B
Profitable — the bottom line is positive
Recent Insider Activity
SEC Form 4 filings — what company insiders are buying and selling
55
NEUTRAL
Mixed insider activity. 0 purchases and 0 sales in the last 90 days — no clear directional signal. Politicians have been buying this name.
| Date |
Insider |
Title |
Type |
Shares |
Value |
| 2026-04-30 |
GIESSELMAN JANET PLAUT |
Director |
|
95 |
$7,750 |
| 2026-04-30 |
NAYYAR NAYAKI R |
Director |
|
401 |
$32,500 |
| 2026-04-28 |
GIESSELMAN JANET PLAUT |
Director |
|
2,350 |
— |
| 2026-04-28 |
PAGE GREGORY R |
Director |
|
3,870 |
— |
| 2026-04-28 |
EVERITT DAVID C |
Director |
|
2,350 |
— |
| 2026-04-28 |
WARD PATRICK J |
Director |
|
2,350 |
— |
| 2026-04-28 |
PREETE KERRY J |
Director |
|
2,350 |
— |
| 2026-04-28 |
POLICINSKI CHRISTOPHER J |
Director |
|
2,350 |
— |
| 2026-04-28 |
LUTZ MARCOS M |
Director |
|
2,350 |
— |
| 2026-04-28 |
NAYYAR NAYAKI R |
Director |
|
2,350 |
— |
Source: SEC Form 4 filings via public data. View all insider activity at
Insider Intelligence
Political Trading Activity
Congressional trading disclosures involving this instrument
| Date |
Politician |
Party |
Type |
Amount |
| 2026-04-13 |
Ro Khanna |
Democrat |
Purchase |
1K–15K |
Source: Congressional disclosure filings. View all political trades at
Insider Intelligence
Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-05-15